Skip to content

Comprative Efficiacy of Tacrolimus 0.1% vs flucinolone onitment in patients with cutaneous lichen planus

Comprative Efficiacy of Tacrolimus 0.1% vs flucinolone onitment in patients with cutaneous lichen planus

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
IRCT
Registry ID
IRCT201407263566N4
Enrollment
50
Registered
2014-08-02
Start date
2014-05-19
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lichen planus. Lichen planus

Interventions

Intervention 1: In the first group Tacrolimus 1% cream will ba applied 2 times daily to cover the entire lesion for 12 weeks. Intervention 2: In the second group flucinolone onitmen will be applied 2
Treatment - Drugs
In the first group Tacrolimus 1% cream will ba applied 2 times daily to cover the entire lesion for 12 weeks.
In the second group flucinolone onitmen will be applied 2 times daily to cover the entire lesion for 12 weeks.

Sponsors

Vice chancellor for research, Tabriz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
2 Years to No maximum

Inclusion criteria

Inclusion criteria: Inclusion criteria: patients with definite diagnose of lichen planus; patients older than 2 years. Exclusion criteria: the presence of other skin diseases; patients using medication that can cause drug-induced lichen planus; history of drug reaction to steroid or Tacrolimus; pregnant women and lactating mothers; mental retarded or physically disabled patients.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
The recovery rate of lichen planus lesions. Timepoint: Monthly, up to 6 months. Method of measurement: Clinical observation.

Secondary

MeasureTime frame
Treatment complication. Timepoint: Monthly, up to 6 months. Method of measurement: Clinical observation.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactEsmail Emami

Tabriz University of Medical Sciences

esmailemamikhatab90@yahoo.com00

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026